Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer

David Goldstein; Daniel Von Hoff; E. Chiorean; Michele Reni; Josep Tabernero; Ramesh Ramanathan; Julia Wilkerson; Marc Botteman; Abdalla Aly; Sandra Margunato-Debay; Brian Lu; Chrystal Louis; Markus Renschler; Desmond McGovern; Chee Lee

doi:10.1093/annonc/mdx262.016

Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer

David Goldstein, Daniel Von Hoff, E. Chiorean, Michele Reni, Josep Tabernero, Ramesh Ramanathan, Julia Wilkerson, Marc Botteman, Abdalla Aly, Sandra Margunato-Debay, Brian Lu, Chrystal Louis, Markus Renschler, Desmond McGovern, Chee Lee

Hematology/Oncology

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Original language	English (US)
Pages (from-to)	iii142-iii144
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	28
DOIs	https://doi.org/10.1093/annonc/mdx262.016
State	Published - Jun 1 2017

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdx262.016

Cite this

Goldstein, D., Von Hoff, D., Chiorean, E., Reni, M., Tabernero, J., Ramanathan, R., Wilkerson, J., Botteman, M., Aly, A., Margunato-Debay, S., Lu, B., Louis, C., Renschler, M., McGovern, D., & Lee, C. (2017). Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 28, iii142-iii144. https://doi.org/10.1093/annonc/mdx262.016

Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer. / Goldstein, David; Von Hoff, Daniel; Chiorean, E. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, 01.06.2017, p. iii142-iii144.

Research output: Contribution to journal › Article › peer-review

Goldstein, D, Von Hoff, D, Chiorean, E, Reni, M, Tabernero, J, Ramanathan, R, Wilkerson, J, Botteman, M, Aly, A, Margunato-Debay, S, Lu, B, Louis, C, Renschler, M, McGovern, D & Lee, C 2017, 'Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 28, pp. iii142-iii144. https://doi.org/10.1093/annonc/mdx262.016

Goldstein D, Von Hoff D, Chiorean E, Reni M, Tabernero J, Ramanathan R et al. Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Jun 1;28:iii142-iii144. doi: 10.1093/annonc/mdx262.016

Goldstein, David ; Von Hoff, Daniel ; Chiorean, E. et al. / Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2017 ; Vol. 28. pp. iii142-iii144.

@article{0472e89bc7ae4053842ff9aa18b40bb6,

title = "Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer",

author = "David Goldstein and {Von Hoff}, Daniel and E. Chiorean and Michele Reni and Josep Tabernero and Ramesh Ramanathan and Julia Wilkerson and Marc Botteman and Abdalla Aly and Sandra Margunato-Debay and Brian Lu and Chrystal Louis and Markus Renschler and Desmond McGovern and Chee Lee",

year = "2017",

month = jun,

day = "1",

doi = "10.1093/annonc/mdx262.016",

language = "English (US)",

volume = "28",

pages = "iii142--iii144",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer

AU - Goldstein, David

AU - Von Hoff, Daniel

AU - Chiorean, E.

AU - Reni, Michele

AU - Tabernero, Josep

AU - Ramanathan, Ramesh

AU - Wilkerson, Julia

AU - Botteman, Marc

AU - Aly, Abdalla

AU - Margunato-Debay, Sandra

AU - Lu, Brian

AU - Louis, Chrystal

AU - Renschler, Markus

AU - McGovern, Desmond

AU - Lee, Chee

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85075629276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075629276&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx262.016

DO - 10.1093/annonc/mdx262.016

M3 - Article

C2 - 32135776

SN - 0923-7534

VL - 28

SP - iii142-iii144

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this